SBC Medical Group (SBC) Competitors

Progyny (NASDAQ:PGNY) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Do institutionals and insiders believe in PGNY or SBC?

94.9% of Progyny shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Comparatively, 89.5% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Does the media prefer PGNY or SBC?

In the previous week, Progyny had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for Progyny and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.32 beat Progyny's score of 0.10 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Progyny	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SBC Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger valuation & earnings, PGNY or SBC?

Progyny has higher revenue and earnings than SBC Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Progyny	$1.17B	1.58	$54.34M	$0.57	37.63
SBC Medical Group	$205.42M	2.26	$46.61M	N/A	N/A

Do analysts recommend PGNY or SBC?

Progyny currently has a consensus price target of $23.45, indicating a potential upside of 9.35%. Given Progyny's stronger consensus rating and higher probable upside, equities research analysts clearly believe Progyny is more favorable than SBC Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Progyny	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.42
SBC Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is PGNY or SBC more profitable?

Progyny has a net margin of 4.33% compared to SBC Medical Group's net margin of 0.00%. SBC Medical Group's return on equity of 26.72% beat Progyny's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Progyny	4.33%	10.90%	7.20%
SBC Medical Group	N/A	26.72%	19.60%

Which has more volatility & risk, PGNY or SBC?

Progyny has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

Summary

Progyny beats SBC Medical Group on 9 of the 14 factors compared between the two stocks.